COMP <GO>
GEHC vs LLY // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
GE HealthCare Technologies Inc. Common Stock (NASDAQ) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: GEHC 4
— LLY 10
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: LLY
LAST: $76.57 (+0.20%) • MKT CAP: $34.55B
options-implied-move
7.40%
LAST: $1,417.54 (+3.19%) • MKT CAP: $1.33T
options-implied-move
6.77%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GEHC VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GEHC | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 40.00% | 83.64% | -43.64 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.20% | 32.36% | -18.16 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 11.1x | 36.4x | -25.32 | GEHC | /valuation <GO> |
| Free Cash Flow Yield | 4.19% | 2.30% | +1.89 | GEHC | /fcf-yield <GO> |
| Operating Margin | 13.40% | 40.21% | -26.81 | LLY | /operating-margins <GO> |
| Net Profit Margin | 10.10% | 31.90% | -21.80 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 4.80% | 45.51% | -40.71 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.19% | 0.49% | -0.30 | LLY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.90 | 9.29 | -7.39 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 9/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 7.40% | 6.77% | +0.63 | LLY | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 74.1 | 77.9 | -3.78 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.15 | 0.51 | +0.64 | GEHC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.4x | 26.3x | -10.85 | GEHC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $34.55B | $1.33T | -$1.30T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GEHC REV | LLY REV | GEHC GROSS % | LLY GROSS % | GEHC FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $20.63B | $65.18B | 40.0% | 83.0% | $1.41B | $16.81B |
| FY 2024 | $19.67B | $45.04B | 41.7% | 81.3% | $1.35B | $8.82B |
| FY 2023 | $19.55B | $34.12B | 44.0% | 79.3% | $876.3M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GEHC // BETA 1.15
LLY // BETA 0.51